UNICA IRIS Institutional Research Information System

SCHERMA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 117.484
NA - Nord America 5.843
AS - Asia 2.278
SA - Sud America 397
AF - Africa 55
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 126.069
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 115.991
US - Stati Uniti d'America 5.735
CN - Cina 925
SG - Singapore 817
SE - Svezia 436
BR - Brasile 339
UA - Ucraina 283
DE - Germania 201
GB - Regno Unito 161
FI - Finlandia 145
VN - Vietnam 130
KR - Corea 76
IN - India 64
CA - Canada 62
FR - Francia 61
TR - Turchia 54
NL - Olanda 50
HK - Hong Kong 35
AR - Argentina 28
BD - Bangladesh 25
MX - Messico 24
PL - Polonia 24
AT - Austria 22
IQ - Iraq 21
JP - Giappone 20
SA - Arabia Saudita 16
ES - Italia 15
MA - Marocco 14
ZA - Sudafrica 14
BE - Belgio 13
CZ - Repubblica Ceca 12
IR - Iran 12
IE - Irlanda 11
EC - Ecuador 10
RU - Federazione Russa 10
PK - Pakistan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
AU - Australia 7
LT - Lituania 7
VE - Venezuela 6
CO - Colombia 5
EG - Egitto 5
HR - Croazia 5
ID - Indonesia 5
IL - Israele 5
JO - Giordania 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
GE - Georgia 4
GR - Grecia 4
HU - Ungheria 4
PA - Panama 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
AM - Armenia 2
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NA - Namibia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
SR - Suriname 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
Totale 126.057
Salva come PNG Salva come JPEG
Città #
Cagliari 112.312
Uta 3.221
Fairfield 589
Ashburn 584
Woodbridge 416
Dallas 397
Chandler 360
Singapore 346
Houston 298
Ann Arbor 279
Nyköping 255
Boardman 248
Seattle 247
Wilmington 208
Beijing 187
Cambridge 186
Jacksonville 150
Dearborn 127
Los Angeles 126
Shanghai 108
New York 100
Santa Clara 94
Hefei 87
Boston 72
Seoul 68
Munich 62
Helsinki 61
Nanjing 59
The Dalles 56
Dong Ket 45
Milan 34
San Diego 34
Buffalo 33
Hong Kong 33
Shenyang 33
Council Bluffs 30
São Paulo 30
Redwood City 29
Turku 29
Washington 29
Chennai 28
Rome 27
Ho Chi Minh City 26
Kocaeli 24
London 24
Denver 23
Guangzhou 21
Redondo Beach 21
Frankfurt am Main 20
Chicago 19
Mountain View 19
Toronto 19
Hanoi 18
Montreal 17
Warsaw 17
Amsterdam 16
Atlanta 16
Tokyo 16
Brooklyn 15
Nuremberg 15
Phoenix 15
Sassari 15
Tianjin 15
Verona 15
Wuhan 14
Brussels 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Orem 13
Poplar 13
Vienna 12
Casablanca 11
Changsha 11
Dublin 11
Arlington 10
Brasília 10
Mexico City 10
Shenzhen 10
Stockholm 10
Tertenìa 10
Johannesburg 9
Lappeenranta 9
Manchester 9
Ningbo 9
Norwalk 9
Orange 9
Porto Alegre 9
Rio de Janeiro 9
San Francisco 9
Columbus 8
Istanbul 8
Nanchang 8
San Sperate 8
Tashkent 8
Auburn Hills 7
Baghdad 7
Belo Horizonte 7
Hangzhou 7
Kunming 7
Totale 122.476
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.629
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.849
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.331
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.324
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.303
Emotional profile of female rats showing binge eating behavior 3.223
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.048
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.937
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.923
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.875
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.836
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.788
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.758
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.681
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.568
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.555
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.482
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.445
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.358
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.354
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.301
Brain activity of anandamide: a rewarding bliss? 2.246
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.192
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.190
Animal Models of Eating Disorders 2.138
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.994
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.926
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.843
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.841
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.756
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.728
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.625
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.618
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.461
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.449
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.418
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.400
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.331
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.313
Cannabinoids and their therapeutic applications in mental disorders 1.217
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.210
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.131
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.093
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.033
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.025
Cannabinoid-opioid interaction in relapse to drug-seeking 1.024
Endocannabinoid system and opioid addiction: behavioural aspects 994
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 992
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 984
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 955
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 936
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 932
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 923
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 920
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 837
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 826
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 798
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 750
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 745
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 743
null 738
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 724
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 715
null 711
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 697
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 679
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 648
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 548
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 538
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 515
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 498
An overall view of the most common experimental models for multiple sclerosis 467
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 458
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 420
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 388
Modeling Anorexia Nervosa 356
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 315
Cannabinoids and reward: Interactions with the opioid system 308
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 295
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 263
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 213
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 206
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 143
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 116
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 108
Antibody conjugates in neuroblastoma: a step forward in precision medicine 95
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 78
Cannabinoid-nicotine interactions 48
Totale 126.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.294 0 0 0 0 0 3.179 2.209 1.580 693 1.323 1.330 980
2021/20227.549 998 507 284 662 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20263.322 749 510 777 635 551 100 0 0 0 0 0 0
Totale 126.393